Live Breaking News & Updates on Ematopoietic

Stay updated with breaking news from Ematopoietic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring

. | April 25, 2023 ....

United States , France General , Castillay Leóp , Jessica Edwards , Monica Irina Dutescu , Pascal Pedini , Dolores Hrusovar , Diamanto Kouniaki , Curtis Lind , Caredx Alloseq , Olivier Aubert , Panagiotis Mallis , Coralie Frassati , Research Use , Caredx Inc , Solutions To Improve Allograft Outcomes On , Alloseq Service , University Hospital Of Salamanca , National Institute Of Blood Transfusion Prof , Department Of Haematology , National Institute Of Blood Transfusion , Paris Transplant Group , European Immunogenetics , Histocompatibility Conference , Greg Seeto , New Ground ,

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -ROCKVILLE, Md., April 13, 2023 (GLOBE NEWSWIRE) ....

United States , Theriva Biologics , Erikr Dubberke , Chris Calabrese , Bella Centre Copenhagen , Theriva Biologics Inc , Safety Monitoring Committee , Washington University School Of Medicine , European Congress , Lifesci Advisors , Company Annual Report On Form , Clinical Microbiology , Infectious Diseases , Clinical Director , Transplant Infectious Diseases , Washington University School , Private Securities Litigation Reform Act , Annual Report , Sci Advisors ,

Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications

MILAN, Italy and NEW YORK, April 03, 2023 Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide. | April 3, 2023 ....

Luigi Naldini , Pierluigi Paracchi , Mary Ann Chang , Tiziana Pollio , Exchange Commission , Globenewswire Inc , Ospedale San Raffaele , Chief Executive Officer , Golden Power Regulation , Glioblastoma Multiforme , Securities Litigation Reform Act , Annual Report , Ann Chang , Genenta Sciences Pa Stock Exchange , Press Release , O Gnta Us36870w1009 ,

Theriva Biologics, Inc.: Theriva Biologics Announces Presentation of Safety and Pharmacokinetic Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

- Data presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - - Analysis of patients receiving meropenem suggest that SYN-004 is well-tolerated with ....

United States , Dennis Riedl , Theriva Biologics , Stevena Shallcross , Mark Schroeder , Chris Calabrese , Lifesci Advisors , Washington University School Of Medicine , Company Annual Report On Form , Theriva Biologics Inc , Washington University , Safety Monitoring Committee , Orlando World Center Marriott , Division Of Oncology , Cellular Therapy Meetings , Chief Executive Officer , Hematopoietic Cell Transplant , Associate Professor , Bone Marrow Transplantation , Washington University School , Germ Cell , Private Securities Litigation Reform Act , Annual Report , Sci Advisors ,

Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization

Sana is developing a hematopoietic stem cell -targeted fusosome with the ability to deliver gene editing material in vivo to repair genetic abnormalities such as those that cause sickle cell disease. | November 29, 2022 ....

United Kingdom , Steve Harr , Sana Biotechnology Inc , South San Francisco , Sana Biotechnology , Quarterly Report , Nc Stock Exchange , Press Release , Ell Sana Us7995661045 ,